Karthik Shekhar is John F. Heil Jr. Professor in the chemical and biomolecular engineering department at the University of California, Berkeley. His laboratory is cross-affiliated with neuroscience, vision science and the Lawrence Berkeley Laboratory. His interests are at the interface of neuroscience, genomics and applied mathematics, and his group uses both experimental and computational approaches to understand how diverse types of neurons in the brain develop and evolve, and how they become selectively vulnerable during diseases. He has received the NIH Pathway to Independence Award, the Hellman Fellowship and the McKnight Fellowship in Neuroscience. He also recently received the Donald E. Noyce Prize for Excellence in Undergraduate Teaching.
Karthik Shekhar
Assistant professor of chemical and biomolecular engineering
University of California, Berkeley
From this contributor
Building a brain: How does it generate its exquisite diversity of cells?
High-throughput technologies have revealed new insights into how the brain develops. But a truly comprehensive map of neurodevelopment requires further advances.
Building a brain: How does it generate its exquisite diversity of cells?
Explore more from The Transmitter
Neuro’s ark: Understanding fast foraging with star-nosed moles
“MacArthur genius” Kenneth Catania outlined the physiology behind the moles’ stellar foraging skills two decades ago. Next, he wants to better characterize their food-seeking behavior.
Neuro’s ark: Understanding fast foraging with star-nosed moles
“MacArthur genius” Kenneth Catania outlined the physiology behind the moles’ stellar foraging skills two decades ago. Next, he wants to better characterize their food-seeking behavior.
Largest leucovorin-autism trial retracted
A reanalysis of the data revealed errors and failed to replicate the results.
Largest leucovorin-autism trial retracted
A reanalysis of the data revealed errors and failed to replicate the results.
NIH scraps policy that classified basic research in people as clinical trials
The policy aimed to increase the transparency of research in humans but created “a bureaucratic nightmare” for basic neuroscientists.
NIH scraps policy that classified basic research in people as clinical trials
The policy aimed to increase the transparency of research in humans but created “a bureaucratic nightmare” for basic neuroscientists.